Q2 2026 Arlo Technologies, Inc. Earnings Call Transcript
Key Points
- Record Q2 2026 results with total revenue of $156 million, up 21% year-over-year, and service revenue of $93 million, up 19%.
- Strong subscriber growth with 298,000 net paid account additions, bringing total paid accounts to 6.3 million, ahead of long-term targets.
- Improved customer metrics: ARPU increased, churn decreased, and lifetime value (LTV) of a paid account rose 15% to $967.
- Adjusted EBITDA grew 70% year-over-year to $31 million, with non-GAAP EPS of $0.28, up 65%.
- Strategic partnerships (ADT, Comcast) progressing well, with ADT Blue launched and Comcast integration on track for potential Q1 2027 launch.
- Upcoming Arlo Secure 7 launch in Q3 2026 expected to introduce new AI features and a higher-priced subscription tier, boosting ARR.
- AloeCare acquisition expanding into new markets (e.g., Home Helpers) with plans for additional partner announcements and growth in 2027.
- Strong capital allocation: $20 million in share repurchases in Q2, with management believing shares are undervalued.
- Raised full-year 2026 guidance for total revenue to $580-$600 million and non-GAAP EPS to $0.90-$1.00.
- Product gross margin remains negative at -11.6% (pro forma, excluding tariff refunds), though improved 220 basis points year-over-year.
- Inventory levels increased to $48.4 million, with inventory turns declining to 5.5 times from 7.7 times last year.
- Q3 2026 revenue guidance of $140-$150 million implies a sequential decline from Q2's record $156 million.
- Service revenue growth of 19% is slightly below the 20% target, and full-year service revenue guidance was not raised despite product revenue growth.
- Dependence on tariff refunds for profitability; Q2 EPS included a $0.07 benefit, and Q3 will see a smaller refund reinvested in growth initiatives.
- Operating expenses increased 16.5% year-over-year due to R&D and strategic partner investments, pressuring near-term margins.
- The shift of Amazon Prime Day to Q2 pulled forward product revenue, potentially impacting Q3 product sales.
- Management's focus on investing in market tests (e.g., AloeCare, small business) may not yield immediate returns, adding uncertainty.
Ladies and gentlemen, thank you for standing by. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session. At that time, if you have a question, you will need to press the star one on your push button phone. I would now like to turn the conference over to Tom and Clark. Please go ahead.
Before we begin the formal remarks, we advise you that today's conference call contains forward-looking statements.
Forward-looking statements include statements regarding our potential future business, operating results and financial condition, including our description of revenue, gross margins, operating margins, earnings per share, expenses, cash outlook, free cash flow and free cash flow margin, ARR and other KPIs, guidance for the third quarter and full year 2026, the long-range plan targets. The rate and timing paid subscriber growth, the commercial launch and momentum of new products and services, the timing and impact of the tariffs, strategic
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
